Yaniv Lustig

Follow

Generating author description...

All published works
Action Title Year Authors
+ Factors associated with the transmission of the delta SARS-CoV-2 variant in households: the Israeli COVID-19 Family Study (ICoFS) 2025 Thomas Cortier
Mayan Gilboa
Maylis Layan
Gili Joseph
Lilac Meltzer
Sharon Amit
Carmit Rubin
Yaniv Lustig
Sharon Alroy‐Preis
Yitshak Kreiss
+ PDF Chat SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022­ and 2023 2024 Yaniv Lustig
Michal Canetti
Victoria Indenbaum
Yovel Peretz
Yael Weiss-Ottolenghi
Ili Margalit
Keren Asraf
Tal Levin
Neta S. Zuckerman
Enosh Tomer
+ PDF Chat Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study 2023 Gili Regev‐Yochay
Yaniv Lustig
Gili Joseph
Mayan Gilboa
Noam Barda
Ilana Gens
Victoria Indenbaum
Osnat Halpern
Shiri Katz-Likvornik
Tal Levin
+ PDF Chat Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021 2022 Ravit Bassal
Lital Keinan-Boker
Dani Cohen
Ella Mendelson
Yaniv Lustig
Victoria Indenbaum
+ PDF Chat SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact 2021 Marc Lipsitch
Florian Krammer
Gili Regev‐Yochay
Yaniv Lustig
Ran D. Balicer
+ Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study 2021 Yaniv Lustig
Carmit Cohen
Asaf Biber
Hanaa Jaber
Yael Becker Ilany
Victoria Indenbaum
Sharon Amit
Michal Mandelboim
Ella Mendelson
Gili Regev‐Yochay
+ BNT162b2 Vaccine-Induced Immune Responses and Dynamics Vary Among Age Groups, Sex and Co-Morbidities: A Longitudinal Prospective Cohort Study 2021 Yaniv Lustig
Einav Sapir
Gili Regev‐Yochay
Carmit Cohen
Ronen Fluss
Liraz Olmer
Victoria Indenbaum
Michal Mandelboim
Ram Doolman
Sharon Amit
+ PDF Chat Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses 2020 Yaniv Lustig
Shlomit Keler
Rachel Kolodny
Nir Ben‐Tal
Danit Atias-Varon
Ekaterina Shlush
Motti Gerlic
Ariel Munitz
Ram Doolman
Keren Asraf
+ PDF Chat Zika Virus in Israeli Travelers: Emergence of Asia as a Major Source of Infection 2018 Eyal Meltzer
Yaniv Lustig
Eli Schwartz
+ PDF Chat Lack of Zika virus antibody response in confirmed patients in non-endemic countries 2017 Yaniv Lustig
Ani Ioana Cotar
Cornelia Svetlana Ceianu
Concetta Castilletti
Hana ZelenĂĄ
Elisa Burdino
Carla van Tienen
Tatjana AvĆĄiÄâ€Ćœupanc
Emma Aarons
Chantal Reusken
+ PDF Chat Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016 2016 Yaniv Lustig
Ella Mendelson
Nir Paran
Sharon Melamed
Eli Schwartz
+ PDF Chat The Clinical Spectrum of Zika Virus in Returning Travelers 2016 Eyal Meltzer
Eyal Leshem
Yaniv Lustig
Giora Gottesman
Eli Schwartz
+ PDF Chat Zika Virus Disease in Traveler Returning from Vietnam to Israel 2016 Eyal Meltzer
Yaniv Lustig
Eyal Leshem
Ran Levy
Giora Gottesman
Rotem Weissmann
Duha Hejleh Rabi
Musa Hindiyeh
Ravit Koren
Ella Mendelson
Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ PDF Chat Zika Virus Disease in Traveler Returning from Vietnam to Israel 2016 Eyal Meltzer
Yaniv Lustig
Eyal Leshem
Ran Levy
Giora Gottesman
Rotem Weissmann
Duha Hejleh Rabi
Musa Hindiyeh
Ravit Koren
Ella Mendelson
3
+ PDF Chat Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection 2021 David S. Khoury
Deborah Cromer
Arnold Reynaldi
Timothy E. Schlub
Adam K. Wheatley
Jennifer A. Juno
Kanta Subbarao
Stephen J. Kent
James A. Triccas
Miles P. Davenport
2
+ PDF Chat Zika Virus Outbreak on Yap Island, Federated States of Micronesia 2009 Mark R. Duffy
Tai-Ho Chen
W. Thane Hancock
Ann M. Powers
Jacob L. Kool
Robert S. Lanciotti
Moses Pretrick
Maria Marfel
Stacey Holzbauer
Christine Dubray
2
+ PDF Chat Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016 2016 Yaniv Lustig
Ella Mendelson
Nir Paran
Sharon Melamed
Eli Schwartz
2
+ PDF Chat The Clinical Spectrum of Zika Virus in Returning Travelers 2016 Eyal Meltzer
Eyal Leshem
Yaniv Lustig
Giora Gottesman
Eli Schwartz
2
+ PDF Chat Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines 2009 Andrea Marshall
Douglas G. Altman
Roger Holder
Patrick Royston
1
+ PDF Chat Zika without symptoms in returning travellers: What are the implications? 2016 MylĂšne Ginier
Andreas Neumayr
Stephan GĂŒnther
Jonas Schmidt‐Chanasit
Johannes Blum
1
+ PDF Chat Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–July 7, 2016 2016 Laura Adams
Melissa Bello-PagĂĄn
Matthew Lozier
Kyle R. Ryff
Carla Espinet
Jomil Torres
Janice PĂ©rez‐Padilla
Mitchelle Flores Febo
Emilio Dirlikov
Alma M Martinez
1
+ PDF Chat False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland 2016 Danielle Gyurech
Julian Schilling
Jonas Schmidt‐Chanasit
P. Cassinotti
Franz Kaeppeli
Marinko Dobec
1
+ PDF Chat Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies 2016 Marc Lipsitch
Ayan Jha
Lone Simonsen
1
+ PDF Chat Longitudinal follow-up of Zika virus RNA in semen of a traveller returning from Barbados to the Netherlands with Zika virus disease, March 2016 2016 Chantal Reusken
Suzan D. Pas
Corine H. GeurtsvanKessel
Ramona Mögling
Jeroen J. A. van Kampen
Thomas Langerak
Marion Koopmans
Annemiek van der Eijk
Eric C. M. Van Gorp
1
+ PDF Chat Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity 2016 Mee Sook Park
Jin Il Kim
Sehee Park
Ilseob Lee
Man‐Seong Park
1
+ Zika virus: History, epidemiology, transmission, and clinical presentation 2017 Byung-Hak Song
Sang-Im Yun
Michael Woolley
Young Min Lee
1
+ Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens 2017 Jean‐Michel Mansuy
Catherine Mengelle
Christophe Pasquier
Sabine Chapuy‐Regaud
Pierre Delobel
Guillaume Martin‐Blondel
Jacques Izopet
1
+ PDF Chat Evaluation of 5 Commercially Available Zika Virus Immunoassays 2017 David Safronetz
Angela Sloan
Derek R. Stein
Emelissa J. Mendoza
Nicole Barairo
Charlene Ranadheera
Leanne Scharikow
Kimberly Holloway
Alyssia Robinson
Maya Traykova-Andonova
1
+ Vaccine waning and mumps re-emergence in the United States 2018 Joseph A. Lewnard
Yonatan H. Grad
1
+ Demographic and Travel Characteristics of Travel-Associated Zika Virus Infection Case-Patients in San Diego County, California (January 1, 2016–March 31, 2017) 2017 Gabriela Escutia
Eric McDonald
Alfonso RodrĂ­guez-Lainz
Jessica M. Healy
1
+ Prevalence of asymptomatic Zika virus infection: a systematic review 2018 Michelle M. Haby
Mariona Pinart
Vanessa ElĂ­as
Ludovic Revéiz
1
+ PDF Chat Covert COVID-19 and false-positive dengue serology in Singapore 2020 Gabriel Yan
Chun Kiat Lee
Lawrence Lam
Benedict Yan
Ying Xian Chua
Anita Y. N. Lim
Kee Fong Phang
Guan Sen Kew
Hazel Teng
Chin Hong Ngai
1
+ PDF Chat Roles and challenges of primary care physicians facing a dual outbreak of COVID-19 and dengue in Singapore 2020 Lawrence Lam
Ying Xian Chua
David Hsien Yung Tan
1
+ Three months of <scp>COVID</scp>‐19: A systematic review and meta‐analysis 2020 Danish Rafiq
Asiya Batool
Mohammad Abid Bazaz
1
+ PDF Chat Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness—A Tropical World Threat 2020 Surat Nunthavichitra
Suttiporn Prapaso
Viravarn Luvira
Sant Muangnoicharoen
Pornsawan Leaungwutiwong
Watcharapong Piyaphanee
1
+ PDF Chat Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies 2020 Hanalise V. Huff
Avantika Singh
1
+ PDF Chat Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections 2020 Quanxin Long
Xiao-Jun Tang
Q L Shi
Qin Li
Haijun Deng
Jun Yuan
Jieli Hu
Wei XĂŒ
Yong Zhang
Fa-Jin Lv
1
+ PDF Chat A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity 2020 Angkana T. Huang
Bernardo García‐Carreras
Matt D.T. Hitchings
Bingyi Yang
Leah C. Katzelnick
Susan M Rattigan
Brooke A. Borgert
C Moreno
Benjamin D. Solomon
Luke Trimmer-Smith
1
+ Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity 2020 Tyler J. Ripperger
Jennifer L. Uhrlaub
Makiko Watanabe
Rachel Wong
Yvonne Castaneda
Hannah A. Pizzato
Mallory R. Thompson
Christine M. Bradshaw
Craig Weinkauf
Christian Bime
1
+ PDF Chat Correlates of protection against SARS-CoV-2 in rhesus macaques 2020 Katherine McMahan
Jingyou Yu
Noe B. Mercado
Carolin Loos
Lisa H. Tostanoski
Abishek Chandrashekar
Jinyan Liu
Lauren Peter
Caroline Atyeo
Alex Zhu
1
+ COVID-19-neutralizing antibodies predict disease severity and survival 2020 Wilfredo F. GarcĂ­a-BeltrĂĄn
Evan C. Lam
Michael G. Astudillo
Diane Yang
Tyler E. Miller
Jared Feldman
Blake M. Hauser
Timothy M. Caradonna
Kiera Clayton
Adam D. Nitido
1
+ PDF Chat Immunological characteristics govern the transition of COVID-19 to endemicity 2021 Jennie S. Lavine
Ottar N. BjĂžrnstad
Rustom Antia
1
+ Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination 2021 Sarah Cobey
Daniel B. Larremore
Yonatan H. Grad
Marc Lipsitch
1
+ Associations of the BNT162b2 COVID-19 vaccine effectiveness with patient age and comorbidities 2021 Idan Yelin
Rachel Katz
Esma Herzel
Tamar Berman-Zilberstein
Amir Ben‐Tov
Jacob Kuint
Sivan Gazit
Tal Patalon
Gabriel Chodick
Roy Kishony
1
+ PDF Chat Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020 2021 Preeti Pathela
Addie Crawley
Don Weiss
Beth Maldin
Jennifer Cornell
Jeff Purdin
Pamela Schumacher
Stacey Marovich
Li Joyce
Demetre Daskalakis
1
+ Extended interval BNT162b2 vaccination enhances peak antibody generation in older people 2021 Helen Parry
Rachel Bruton
Christine Stephens
Kevin Brown
Gayatri Amirthalingam
Bassam Hallis
Ashley Otter
Jianmin Zuo
Paul Moss
1
+ The indirect effect of mRNA-based Covid-19 vaccination on unvaccinated household members 2021 Jussipekka Salo
Milla HĂ€gg
Mika Kortelainen
Tuija Leino
Tanja Saxell
Markku Siikanen
Lauri SÀÀksvuori
1
+ Interpreting vaccine efficacy trial results for infection and transmission 2021 Marc Lipsitch
Rebecca Kahn
1
+ PDF Chat Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals 2021 Oren Milman
Idan Yelin
Noga Aharony
Rachel Katz
Esma Herzel
Amir Ben‐Tov
Jacob Kuint
Sivan Gazit
Gabriel Chodick
Tal Patalon
1
+ Effect of Vaccination on Household Transmission of SARS-CoV-2 in England 2021 Ross Harris
Jennifer Hall
Asad Zaidi
Nick Andrews
J Kevin Dunbar
Gavin Dabrera
1
+ Seroprevalence of SARS-CoV-2 antibody among individuals aged above 15 years and residing in congregate settings in Dire Dawa city administration, Ethiopia 2021 Tamrat Shaweno
Ibrahim Abdulhamid
Lemlem Bezabih
Daniel Teshome
Behailu Derese
Hiwot Tafesse
Debebe Shaweno
1
+ Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study 2021 Maylis Layan
Mayan Gilboa
Tal Gonen
Miki Goldenfeld
Lilac Meltzer
Alessio Andronico
Nathanaël Hozé
Simon Cauchemez
Gili Regev‐Yochay
1
+ Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines 2021 Rebecca Kahn
Stephanie J. Schrag
Jennifer R. Verani
Marc Lipsitch
1
+ PDF Chat Viral loads observed under competing strain dynamics 2021 James A. Hay
Lee Kennedy‐Shaffer
Michael J. Mina
1
+ PDF Chat Influence of age on the effectiveness and duration of protection in Vaxzevria and CoronaVac vaccines 2021 Thiago Cerqueira‐Silva
VinĂ­cius de AraĂșjo Oliveira
JĂșlia Moreira Pescarini
Juracy Bertoldo
Tales Mota Machado
Renzo Flores-Ortiz
Gerson Oliveira Penna
Maria Yury Ichihara
Jacson VenĂąncio de Barros
Viviane Boaventura
1
+ Effectiveness of BNT162b2 mRNA COVID-19 Vaccine Against SARS-CoV-2 Variant Beta (B.1.351) Among Persons Identified Through Contact Tracing in Israel 2021 Shepherd Roee Singer
Frederick J. Angulo
David L. Swerdlow
John M. McLaughlin
Itay Hazan
Netanel Ginish
Emilia Anis
Ella Mendelson
Orna Mor
Neta S. Zuckerman
1
+ Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK 2021 Koen B. Pouwels
Emma Pritchard
Philippa C. Matthews
Nicole Stoesser
David W. Eyre
Karina-Doris Vihta
Thomas House
Jodie Hay
John I. Bell
John Newton
1
+ Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine 2021 Matan Levine-Tiefenbrun
Idan Yelin
Hillel Alapi
Rachel Katz
Esma Herzel
Jacob Kuint
Gabriel Chodick
Sivan Gazit
Tal Patalon
Roy Kishony
1
+ Estimating Vaccine Efficacy Against Transmission via Effect on Viral Load 2021 Lee Kennedy‐Shaffer
Rebecca Kahn
Marc Lipsitch
1
+ PDF Chat Population impact of SARS-CoV-2 variants with enhanced transmissibility and/or partial immune escape 2021 Mary Bushman
Rebecca Kahn
Bradford P. Taylor
Marc Lipsitch
William P. Hanage
1
+ PDF Chat Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021 2021 Heather M. Scobie
Amelia G. Johnson
Amitabh B. Suthar
Rachel Severson
Nisha B. Alden
Sharon Balter
Daniel Bertolino
David Blythe
Shane Brady
Betsy L. Cadwell
1
+ SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 2021 Ann R. Falsey
Robert W. Frenck
Edward E. Walsh
Nicholas Kitchin
Judith Absalon
Alejandra Gurtman
Stephen Lockhart
Ruth Bailey
Kena A. Swanson
Xia Xu
1
+ Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK 2021 Koen B. Pouwels
Emma Pritchard
Philippa C. Matthews
Nicole Stoesser
David W. Eyre
Karina-Doris Vihta
Thomas House
Jodie Hay
John I. Bell
John Newton
1